You’re listening to Project Oncology on ReachMD. On this episode, sponsored by Lilly, we’re going to hear from Dr. Chandrajit P. Raut, who’s a Professor of Surgery at Harvard Medical School and the Chief of the Division of Oncology at Brigham and Women’s Hospital. Dr. Raut will be giving a presentation at the upcoming 2021 American Society of Clinical Oncology Annual Meeting titled, “Surgical Management of Breast Angiosarcoma: Mastectomy and Beyond.” Here’s Dr. Raut now giving us a sneak preview of what he’ll be talking about at the conference.
Hello, I’ll be giving a talk at the upcoming ASCO annual meeting about the surgical management of breast angiosarcoma. I hope that this talk will allow breast oncologists, breast surgeons, sarcoma oncologists, sarcoma surgeons to think about the biology of angiosarcoma of the breast; think about how that differs between primary and radiation-associated angiosarcoma, and how that allows us to make treatment decisions that are a bit different than for the management of breast ductal carcinoma and breast lobular carcinoma. It’s a very different entity and even the two different types of breast angiosarcoma have very different biologies, they arise in very different parts of the breast and they affect different categories of women. And I think that carefully thinking about those presentations will allow the surgeon in particular to make what I think is the right treatment decision. And importantly, breast angiosarcoma arising after prior radiation therapy really has to be thought of as a field defect of the breast skin and that is something that I’ll be highlighting in my talk.
This episode of Project Oncology was sponsored by Lilly. To access other episodes of this series, visit ReachMD.com/Project-Oncology, where you can Be Part of the Knowledge. Thanks for listening!